The Business Journals

Elephas Biosciences raises $55 million led by Madison-based investors

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Madison-based cancer ...
Morningstar

ELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY ...

MADISON, Wis., Jan. 8, 2026 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, ...
Morningstar

ELEPHAS BIOSCIENCES ANNOUNCES NEW RESEARCH PARTNERSHIP WITH THE UNIVERSITY OF LOUISVILLE TO STUDY ADVANCED STAGE SOLID CANCER TUMORS IN COLORECTAL ...

Three Investigator-Initiated Trials (IITs) to utilize the Elephas Live™ Platform to evaluate the impact of a combination therapy of surgical intervention and immunotherapy MADISON, Wis., Feb. 23, 2026 ...
Business Wire

Elephas to Show First Data on Breakthrough Oncology Diagnostics Platform at American Association for Cancer Research

MADISON, Wis.--(BUSINESS WIRE)--Elephas Biosciences Corporation (Elephas), a live tumor imaging company developing novel cancer diagnostic solutions, announced today the acceptance of three abstracts ...